Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    - A consolidated Locations section was added listing study sites across Alabama, California, Georgia, New York, and Texas, with the previous state-specific location headings removed. The page revision was updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T15:16:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T14:46:44.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Notice about potential government funding delays was removed. The core study information remains unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:31:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Posted study results are now visible on the page, and the study record dates have been updated to include Results First Posted 2025-07-25.
    Difference
    0.4%
    Check dated 2025-10-27T21:12:56.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page updates to include a government funding lapse notice and a status update about operating conditions, plus a new version label (v3.2.0) while removing the old version (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T08:23:21.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T04:56:18.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.